Schedule 13G ownership disclosure

Aptose Biosciences, Inc.

Security class unavailable · CUSIP: 03835T200

Event date: 2020-02-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-20-000268
Form type
SC 13G/A
Filer
Abramson Herbert
CIK
CIK 1354542
Filed
Feb 04, 2020
Reporting period
Feb 04, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub